REED ELIZABETH E (SVP, GC & Corporate Secretary) sold 8.7% of their position (10K shares) of TRAVERE THERAPEUTICS, INC. on the open market
Open‑market sale worth $280.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/18/2026ACC: 0001283303-26-000006
Officer· SVP, GC & Corporate Secretary
Since Nov 2018
-10K
Net shares
Net seller
$280.9K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
10K acquired · 20K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+10K
Price / share
$19.08
Trade value
$190.80K
% of position
9.5%
3/16/2026
105.21K→115.21K
Common Stock
Direct
Shares
−10K
Price / share
$28.09
Trade value
$280.86K
% of position
8.7%
3/16/2026
115.21K→105.21K
Total
Net shares
+0.00
Net value
-$90.06K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/16/2026 | M · Option Exercise | +10K | $19.08 | $190.80K | 9.5% | 105.21K | 115.21K |
| Common Stock Direct | 3/16/2026 | S · Sale | −10K | $28.09 | $280.86K | 8.7% | 115.21K | 105.21K |
| Total | +0.00 | -$90.06K | ||||||
Derivative Transactions1
Employee stock option (right to buy)
Direct
Converts to
Common Stock
10K shares
Shares
−10K
Strike price
19.08
Held after
10K
Exercisable
—
3/16/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee stock option (right to buy) Direct | Common Stock10K shares | 3/16/2026 | M · Option Exercise | −10K | 19.08 | — | 10K |